Big Pharma

16 posts

Colossal Wrongdoings by Big Pharma – Pfizer and COVID-19 Vaccine – Asrar Qureshi’s Blog Post #1095

Asrar Qureshi’s final blog post on Big Pharma critiques Pfizer’s handling during the COVID-19 pandemic, highlighting aggressive contract negotiations and lack of transparency. While Pfizer’s vaccine was pivotal globally, its commercial tactics raised ethical concerns and exposed power imbalances, prompting calls for reforms in pharmaceutical governance to prioritize public health over profits.
Share
View Post
  • 5 min

Colossal Wrongdoings by Big Pharma – Servier – Asrar Qureshi’s Blog Post #1094

Benfluorex, marketed as Mediator, was widely prescribed for diabetes and weight loss in France until its 2009 withdrawal due to severe health risks, causing 500-2,000 deaths. Dr. Irène Frachon’s investigation revealed systemic regulatory failures and corporate negligence. The scandal prompted significant reforms in France’s drug safety oversight to enhance transparency and accountability.
Share
View Post
  • 6 min

Colossal Wrongdoings by Big Pharma – Insulin Price Gouging – Asrar Qureshi’s Blog Post #1092

The blog post discusses the insulin price gouging crisis that began around 2000, with prices soaring due to manipulation by major manufacturers Eli Lilly, Novo Nordisk, and Sanofi. This crisis has significant implications for patients’ health and financial well-being, highlighting ethical issues in pharmaceutical capitalism and calling for urgent reform to ensure accessibility.
Share
View Post
  • 6 min

Colossal Wrongdoings by Big Pharma – Johnson & Johnson – Asrar Qureshi’s Blog Post #1091

Johnson & Johnson’s talcum powder scandal reveals a troubling history of alleged asbestos contamination and corporate negligence. Despite decades of evidence suggesting health risks, the company continued to market its products as safe. The backlash resulted in thousands of lawsuits, reputational damage, and a shift towards cornstarch alternatives as trust eroded.
Share
View Post
  • 5 min

Colossal Wrongdoings by Big Pharma – GSK – Asrar Qureshi’s Blog Post #1090

Asrar Qureshi’s blog post on Pharma Veterans highlights the systemic issues within the pharmaceutical industry, exemplified by GlaxoSmithKline’s $3 billion settlement for fraud and misconduct in 2012. The case underscores the need for stronger regulatory oversight, ethical practices, and whistleblower protection to prevent future harmful corporate behavior in healthcare.
Share
View Post
  • 5 min

Colossal Wrongdoings by Big Pharma – Vioxx – Asrar Qureshi’s Blog Post #1089

Asrar Qureshi’s blog post discusses the Vioxx scandal, highlighting Big Pharma’s greed and ethical failures. Vioxx, promoted as a painkiller, concealed severe cardiovascular risks, leading to thousands of health issues. Merck faced substantial lawsuits and settlements, yet corporate accountability remains questionable, emphasizing the need for stronger regulation and transparency in pharmaceuticals.
Share
View Post
  • 6 min

Expected Changes for Contract Research Organizations – Asrar Qureshi’s Blog Post #1040

This blog post by Asrar Qureshi discusses the role of Contract Research Organizations (CROs) in pharmaceutical development, including their services like clinical trial management and regulatory support. It highlights challenges and evolving trends in the industry, such as technology integration and changing sponsor needs, emphasizing the importance of adaptation for CROs’ future success.
Share
View Post
  • 5 min

Ethical Issues in Pharmaceutical Marketing – Asrar Qureshi’s Blog Post #1005

Asrar Qureshi’s blog post discusses the unique ethical challenges of pharmaceutical marketing, emphasizing the distinction between customers (doctors) and consumers (patients). It highlights issues like misleading advertising, targeting vulnerable populations, off-label promotions, exaggerated disease prevalence, and undue influence on healthcare decision-making. Collaboration is essential to promote ethical practices in the industry.
Share